• Subscribe
  • About us
  • Advertise with us

NeuroSens

Menu

Skip to content
  • Home
  • Neurology
  • Psychiatry

Topic: MS

Are opinions changing on changing therapies in MS?

October 22, 2019  

New developments in secondary-progressive MS – ECTRIMS 2019

October 10, 2019  

Report on higher-efficacy therapies in MS – ECTRIMS 2019

October 2, 2019  

ECTRIMS 2019 SLIDE DECK

September 26, 2019  

ECTRIMS 2019 DAILY REPORT – SATURDAY EDITION

September 14, 2019  

ECTRIMS 2019 DAILY REPORT – FRIDAY EDITION

September 13, 2019  

ECTRIMS 2019 DAILY REPORT – THURSDAY EDITION

September 12, 2019  

Progressive MS trials – design and interpretation

September 4, 2019  

Ponesimod – phase III results in MS

July 31, 2019  

¿Quién es más inerte?

July 24, 2019  
Previous
21
22
23
24
25
Next

Browse by Topic

  • MS (442)
  • EAN 2026 (2)
  • CLINICAL CASES (21)
  • AAN 2026 (3)
  • ACTRIMS Forum 2026 (4)
  • EPILEPSY (38)
  • AES 2025 (1)
  • BIOMARKERS IN MS (61)
  • ECTRIMS 2025 (7)
  • Library (18)
  • EAN 2025 (2)
  • AAN 2025 (5)
  • ACTRIMS 2025 (6)
  • AES 2024 (1)
  • ECTRIMS 2024 (6)
  • EAN 2024 (3)
  • AD (85)
  • AAN 2024 (5)
  • ACTRIMS Forum 2024 (2)
  • PD (77)
  • COVID-19 (58)
  • MIGRAINE (25)
  • DEPRESSION (36)
  • STROKE (22)
  • SCHIZOPHRENIA (25)
  • DEMENTIA (10)
  • SLEEP (2)
  • PAIN (3)
  • BPD (4)
  • ALS (1)

Popular Posts

  • Proton pump inhibitors linked to neurological conditions posted on November 29, 2019
  • Ofatumumab – new data on efficacy and safety posted on April 14, 2025
  • High-efficacy DMTs for MS: the year in review posted on December 1, 2025
Copyright 2026 Lind Publishing Inc All rights reserved. Developed by Integration New Media, INC. (INM)
Contact Us Terms and Conditions